Sign in or Register
- Sign In / Register

Database
Quick Search
News & Analysis
Research
- Quarterly M&A Deals
Bookstore
Events
- Global events calendar

Contact us
Sign-in FAQ
About us
Suggest a story
Subscribe

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Contact us
Sign-in FAQ
About us
Suggest a story
Subscribe

Sign in or Register
- Email
  
  Need help signing in?
  
  Issues with signing in? Click here
  
  Don't have an account? Register now

Database
Quick Search
News & Analysis
Research
- Quarterly M&A Deals
Bookstore
Events
- Global events calendar

Return to search

Atlas and Glaxo back Austrian biotech business

1 April 2009

Create an account to continue reading

Gain instant access to our expert editorial analysis and in-depth insight.

Register for free

Already have an account? Sign in

TAGS
Firms and Funds

Share this

MOST RECENT

Butterfly Equity completes $1.95bn take-private buyout of luxury wine company Duckhorn
Five sectors top of mind for dealmakers in 2024: Food, entertainment, accounting, direct care and onshoring
NEA to take healthcare firm NeueHealth private for $1.3bn

UPCOMING EVENTS

10-12 March
Ritz Carlton, Grande Lakes, Orlando

View all events >

NEWSLETTERS & OPINION

Five sectors top of mind for dealmakers in 2024: Food, entertainment, accounting, direct care and onshoring
Thoma Bravo, Haveli among GPs keen on listed companies; PE goes for European service deals in 2024
Clarion beats the clock on Arthur Murray deal; PAG Asia Capital to sell Lexmark to Xerox

PE DEALS

Butterfly Equity completes $1.95bn take-private buyout of luxury wine company Duckhorn
NEA to take healthcare firm NeueHealth private for $1.3bn
Mutares agrees to buy GDL Anläggning & Miljö from GDL Transport

Agri Investor
Buyouts
Infrastructure Investor
New Private Markets
PERE
Private Equity International
Private Debt Investor
Private Funds CFO
RCW
Real Estate Capital Europe
PERE Credit
Responsible Investor
Secondaries Investor
Venture Capital Journal

Home
About PE Hub
Contact us
Sign In FAQ
Privacy Notice
Cookie Notice
Terms & Conditions

© PEI Group

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

To register, please review and accept our terms and conditions and privacy notice.

I accept:

Already registered? Click here to login

Sign in to your account

Get limited access to our industry news, analysis and data, plus regular email updates

Don't have an account? Click here to register

Sign in to your account

Email address

Email address not recognised.

Don't have an account? Click here to register

Nearly there!

A verification email is on its way to you. Please check your spam or junk folder just in case.

If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.

Copyright PEI Media

Not for publication, email or dissemination

Share with other subscribers

Only logged in subscribers of this site will be able to access the shared article.